InterventionsHuman trial109 patients12 monthsRandomised trial

Oral vitamin C supplementation in patients with clonal cytopenia of undetermined significance or lower-risk myeloid malignancies: Results from EVITA, a phase 2 randomized, placebo-controlled trial

Figure 1. EVITA trial profile. Screening, randomization, treatment, long‐term follow‐up, and analysis in the EVITA study.
Open the figure at full size
Figure 1. EVITA trial profile. Screening, randomization, treatment, long‐term follow‐up, and analysis in the EVITA study.EVITA trial profile. Screening, randomization, treatment, long‐term follow‐up, and analysis in the EVITA study.Mikkelsen et al.

Cancer

The paper

Mikkelsen SU, Al-Mousawi A, Puglisi AB et al.

Cancer · 21 Sep 2026

doi.org/10.1002/cncr.70549PubMed 42764731

More on Inflammation